Showing results (6291-6300 of 14,264) with videos related to

Sort By:
Pageof 1,427
Diabetes|March 1, 2006
SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathyJae Hyeon Kim, Hyoung Doo Shin, Byung Lae Park, et al.
Diabetes|November 1, 1976
Reversal of somatostatin inhibition of insulin and glucagon secretionS J Bhathena, P V Perrino, N R Voyles, et al.
Diabetes|November 1, 1976
Treatment of insulin-induced lipoatrophyS G Hulst
Diabetes|December 1, 1976
Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitusP Felig, J Wahren, R Sherwin, et al.
Diabetes|December 1, 1976
Leucocyte-migration inhibition induced by uveoretinal antigen in patients with diabetic retinopathyZ Aviner, W L Henley, S Okas, et al.
Diabetes|March 2, 2002
Effect of AICAR treatment on glycogen metabolism in skeletal muscleWilliam G Aschenbach, Michael F Hirshman, Nobuharu Fujii, et al.
Diabetes|March 2, 2002
Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exerciseFarah S L Thong, Wim Derave, Bente Kiens, et al.
Diabetes|March 2, 2002
Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistanceSylvie Franckhauser, Sergio Muñoz, Anna Pujol, et al.
Diabetes|March 2, 2002
Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic ratsSimon A Hinke, Richard W Gelling, Raymond A Pederson, et al.
Diabetes|March 2, 2002
NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1Michael C Lawrence, Harshika S Bhatt, Richard A Easom
Pageof 1,427